arrow-positive MNK - Mallinckrodt Plc 4.53 -0.05 (-1.09%)

As of August 20, 2019 6:30 pm EDT
Add to Watchlist

Quote Detail

Last 4.53
Change -0.05
Change % -1.09
Bid 4.56 X 600
Ask 4.68 X 5000
Volume 7.35 M
Shares 83.81 M
Market Cap 384.76 M
   
Open 4.63
High 5.44
Low 4.45
Prev Close 4.58
52 Wk High 36.65
52 Wk Low 3.85
EPS -41.07
P/E -0.11
Div Yield n.a.

Market Headlines

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK 08/20/2019 03:16PM

NEW YORK, Aug 20, 2019 (GLOBE NEWSWIRE via COMTEX News Network) -- Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc ("Mallinckrodt" or the "Company")...

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 08/20/2019 10:15AM

LOS ANGELES, Aug 20, 2019 (GLOBE NEWSWIRE via COMTEX News Network) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against...

Cancer Drugs Projected to Generate the Most in Pharma Revenues 08/20/2019 08:30AM

PALM BEACH, Florida, Aug. 20, 2019 /PRNewswire via COMTEX News Network/ -- Cancer drug market revenues have been steadily rising in the past few years and all indicators predict that they will...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, Aclaris Therapeutics, and Curaleaf and Encourages Investors to Contact the Firm 08/18/2019 07:30PM

NEW YORK, Aug 18, 2019 (GLOBE NEWSWIRE via COMTEX News Network) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of...